Randomized, placebo-controlled, double-bind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
Articolo
Data di Pubblicazione:
2013
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Rougier, P; Riess, H; Manges, R; Karasek, P; Humblet, Y; Carone, C; Santoro, A; Assadouriann, S; Hatteville, L; Phillip, P A
Link alla scheda completa:
Pubblicato in: